Claire B Larmonier
Claire B Larmonier is an expert in Gastroenterology at Institut Bergonié (France). Claire B Larmonier has authored 43 publications, the most recent in 2024. SLR score: 127 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2008 - 2024
Number : 43
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretation. PMID 38481055 — genes, cell transformation, neoplastic, neoplasms, fumarates, chromosome aberrations, leiomyoma, fumarate hydratase | Genes Chromosomes Cancer | 2024 | 6 |
| The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor Features. PMID 37307879 — pathology, rna, muscle, smooth, neoplasms, leiomyoma, comparative genomic hybridization, muscles, leiomyosarcoma, cluster analysis, endometrial stromal tumors, sarcoma, endometrial stromal, smooth muscle tumor | Mod Pathol | 2023 | 17 |
| An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy. PMID 35759853 — neoplasm, residual, risk, prognosis, drug therapy, triple negative breast neoplasms, cells, therapeutics, genes, chemotherapy | ESMO Open | 2022 | 11 |
| IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity. PMID 33837065 — cells, therapeutics, neoplasms, adaptive immunity, t-lymphocytes, tumor microenvironment, car-t cell | Cancer Discov Top journal | 2021 | 125 |
| IDO Targeting in Sarcoma: Biological and Clinical Implications. PMID 32194552 — sarcoma, enzymes, immune system diseases, plasma, immunotherapy, cells, therapeutics, neoplasms, kynurenine, tryptophan, genes, gene expression, indoleamine-pyrrole 2,3,-dioxygenase | Front Immunol | 2020 | 26 |
LeadR Networks
Main global connection map